|
|
|
|
Cell culture media isn’t one-size-fits-all. Its performance hinges on more than just selecting a standard medium. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.
|
|
|
|
|
AAV vectors continue to play a central role in gene therapy, yet consistently clearing product‑related impurities remains one of the most persistent obstacles. Gain insight into how cell line development and process optimization are advancing rAAV production.
|
|
|
|
|
Gene therapies are poised to reach far beyond the realm of rare diseases, opening the door to treatments for more common conditions where existing options fall short. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.
|
|
|
|
|
Gene therapy is entering a pivotal moment in modern medicine. It is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.
|
|
|
|
|
Fixed‑bed bioreactors are changing how teams scale viral vector production, offering a way to move from early development to full manufacturing. Examine a system that bridges the gap with data confirming consistent performance across scales.
|
|
|
|
|
|
Powering Production Of Viral Vector-Based Therapies
|
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. Explore GMP-compliant, end-to-end manufacturing solutions that are designed to support the development and commercialization of advanced medicines across multiple modalities.
|
|
• Request Information
|
|
|
|
|
|
|
|
